Gujarat biopharma firm to invest Rs 25 crore in Hyderabad

The company wants to establish a R&D and innovation centre in Genome Valley by this year-end.

Published: 11th January 2023 09:53 AM  |   Last Updated: 11th January 2023 09:53 AM   |  A+A A-

Online pharmacies

For representational purposes

By Express News Service

HYDERABAD:  Gujarat-based company Meteoric Biopharmaceuticals, a first-generation biopharma enterprise and a renowned name in the global bio-pharmaceutical landscape with over 100 products is planning to invest Rs 25 crore in Hyderabad.

The company wants to establish a R&D and innovation centre in Genome Valley by this year-end. It has chalked out aggressive growth plans and is working towards introducing novel, cost-effective ingredients and formulations in the biopharmaceutical space through innovative research.

The company also plans to launch more concept-based finished nutraceuticals products. Meteoric Biopharmaceuticals currently has 10 patents and over 50 trademarks to its name. It has two production areas and two fully functional labs & R&D centre for a microbiology and enzyme portfolio.

Gaurav Kaushik, Managing Director and CEO - Meteoric Biopharmaceuticals, said: “Our future plans include launching synbiotics (combinations of pre and probiotics), expanding our probiotics and enzymes production capacity, introducing a unique formulation for down syndrome and further expanding exports.

Now we are on Telegram too. Follow us for updates
TAGS
Meteoric Biopharmaceuticals
India Matters

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.